Coronavirus Treatment: Plasma Therapy of Critical COVID-19 Patients

India is expected to soon begin the clinical trails of plasma therapy as a potential treatment for severe COVID-19 cases. The Indian Council of Medical Research (ICMR) has approved it on 10 April.

The number of people getting infected by the deadly novel coronavirus in India has been increasing with every passing day. And to tackle this pandemic, the country is getting ready for its first clinical trial of the Plasma Treatment, which will be used to potentially treat and cure critical COVID-19 patients. This report comes in after the official announcement of the same by the Indian Council of Medical Research (ICMR), the country’s apex body in this particular field. 

Also Check,

About Course:

"Did you Know? In this pack you will get All new content we launch in the next 3 months"

This is the most recommended and NRA-CET ready Pack!

Use Code 'DREAM' to avail at best price today

This package Includes IBPS PO Study Material -  Subscribe Now

About Bank Mahapack
If you are preparing for more than 1 Banking & Insurance exams then this is the pack we recommend you buy.

It is most cost effective and you get access to 100% digital content for Bank & Insurance exams on Adda247.

Banking & Insurance Exams Covered in this Pack

Additionally, you can crack any private bank job exam with content in this pack.


Bank & Insurance Mahapack Highlights 

  • Structured course content
  • Recorded classes available if you miss any live class
  • Previous Years’ Papers of all upcoming exams.
  • Full Length Mocks based on the latest pattern with detailed solutions (video solutions for certain topics)
  • Topic level knowledge tests
  • Strategy sessions, time management & Preparation tips from the experts


Validity: 3 Months

Note: This package is not a part of Double Validity Offer

Bank Maha Pack
  1. Unlimited Live Classes & Recorded Video Courses
  2. Unlimited Tests and eBooks
  3. 1 Lakh+ Selections
  1. 24 Months
  2. 1 Month
  3. 3 Months
6199 516/month

In a recent press conference held by the Health Ministry, the Director of the Indian Institute of Epidemiology, Manoj Murhekar, has stated that the ICMR is currently working to finalise the protocol for the official clinical trial of the Plasma Treatment, which will most likely begin after the Drugs Controller General of India (DCGI) gives it the final approval. 

If approved, the treatment will be conducted on those patients who are on ventilators and under the clinical trial mode. Post that, the treatment will be recommended for all patients. This comes in after the treatment was found to have had successful results in other countries which conducted limited clinical trials of the same. In India, Kerala is the first state to have received the approval from ICMR to begin this trial.  


Plasma Treatment, also known as Convalescent Plasma Therapy, has also undergone a few clinical trials in China as well as in the United States of America. Furthermore, these trials show that the treatment has worked on the respiratory diseases such as MERS and SARS. 

Coronavirus Case Count Coronavirus Do’s & Don’ts List of Exams Postponed Timeline of India’s Response
Precautions You Should Take Govt. Jobs for Graduates Corona Relief Package Highest Paying Govt Jobs

The Plasma Treatment involves injecting COVID-19 patients with the plasma. This plasma will be taken from people who have already recovered from the infection. This is because their bodies have already generated the antibodies which are required to fight and tackle the novel coronavirus. 

The Plasma Treatment is a very important development taken in this regard, especially since there is no tried and tested drug or vaccine available to fight the virus as of now. 

Also Check: List of Important Days in April


Convalescent Plasma Therapy treatment works on the basic principle that the antibodies of a person who has recovered from the virus can help a sick person to recover as well. These antibodies are present in the recovered person’s plasma, which is the yellowish liquid part of the blood. 

This means that people who had earlier tested positive for coronavirus, and have since recovered, in addition to showing no signs of the infection for at least two to three weeks, will be the ones selected as donors of the plasma. 


Plasma Treatment has previously been successful in tackling other epidemics, including the SARS, H1N1 as well as MERS. It has also been used to treat cases of mumps and measles in the past. The early trials of the treatment for COVID-19, especially in the US and China have given encouraging results too. In one such trial, 10 patients from Wuhan, who were all critically ill, were transfused with one dose of the convalescent plasma from a donor. They eventually showed improvement in the clinical symptoms within three days. 

Furthermore, the levels of Coronavirus in their blood disappeared completely in seven to ten days, with no side effects whatsoever. Researchers of the treatment consider the Plasma Therapy a “promising solution” for COVID-19 patients. 

Click Here to Register for Bank Exams 2020 Preparation Material